| Issue Date | Title | Author(s) |
| 2015-06-01 | Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection | Arora, S; Haghi, M; Loo, CY; Traini, D; Young, PM; Jain, S |
| 2005-05-28 | A further study to investigate the detection and enhancement of latent fingerprints using visible absorption and luminescence chemical imaging | Payne, G; Reedy, B; Lennard, C; Comber, B; Exline, D; Roux, C |
| 2010-12-03 | Analytical separations of mammalian decomposition products for forensic science: A review | Swann, LM; Forbes, SL; Lewis, SW |
| 2010-04-15 | Elemental bio-imaging of thorium, uranium, and plutonium in tissues from occupationally exposed former nuclear workers | Hare, D; Tolmachev, S; James, A; Bishop, D; Austin, C; Fryer, F; Doble, P |
| 2022-12 | Reducing educational disparities between Australian adolescents in regional and metropolitan communities: The compensatory effects of extracurricular activities. | O'Donnell, AW; Redmond, G; Thomson, C; Wang, JJJ; Turkmani, S |
| 2012-02-28 | Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting | Shimoni, O; Postma, A; Yan, Y; Scott, AM; Heath, JK; Nice, EC; Zelikin, AN; Caruso, F |
| 2003-11-01 | Low Preconception Body Mass Index Is Associated with Birth Outcome in a Prospective Cohort of Chinese Women | Ronnenberg, AG; Wang, X; Xing, H; Chen, C; Chen, D; Guang, W; Guang, A; Wang, L; Ryan, L; Xu, X |
| 2022-10-22 | Statistical analysis plan for the stepped wedge clinical trial Healing Right Way-enhancing rehabilitation services for Aboriginal Australians after brain injury. | Armstrong, E; Rai, T; Hersh, D; Thompson, S; Coffin, J; Ciccone, N; Flicker, L; Cadilhac, D; Godecke, E; Woods, D; Hayward, C; Hankey, GJ; McAllister, M; Katzenellenbogen, J |
| 2015-01 | A SNaPshot of next generation sequencing for forensic SNP analysis. | Daniel, R; Santos, C; Phillips, C; Fondevila, M; van Oorschot, RAH; Carracedo, A; Lareu, MV; McNevin, D |
| 2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |
